110 related articles for article (PubMed ID: 11146252)
1. Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases.
Gibb AP; Crichton M
Diagn Microbiol Infect Dis; 2000 Dec; 38(4):255-7. PubMed ID: 11146252
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of bloodstream infections caused by extended-spectrum beta-lactamase-producing E. coli and Klebsiella species.
Skippen I; Shemko M; Palmer C; Shetty N
Br J Biomed Sci; 2006; 63(1):1-4. PubMed ID: 16613133
[TBL] [Abstract][Full Text] [Related]
3. Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method.
Carter MW; Oakton KJ; Warner M; Livermore DM
J Clin Microbiol; 2000 Nov; 38(11):4228-32. PubMed ID: 11060096
[TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
[TBL] [Abstract][Full Text] [Related]
5. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
Vercauteren E; Descheemaeker P; Ieven M; Sanders CC; Goossens H
J Clin Microbiol; 1997 Sep; 35(9):2191-7. PubMed ID: 9276386
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the E-test method with an automated bacterial identification and antimicrobial susceptibility detection system for screening extended-spectrum beta-lactamase producers.
Ozakin C; Sinirtaş M; Sevgican E; Kazak E; Gedikoglu S
Scand J Infect Dis; 2003; 35(10):700-3. PubMed ID: 14606607
[TBL] [Abstract][Full Text] [Related]
7. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
9. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
Kohner PC; Robberts FJ; Cockerill FR; Patel R
J Clin Microbiol; 2009 Aug; 47(8):2419-25. PubMed ID: 19494061
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
11. Detection of extended spectrum beta-lactamase production in clinical isolates of Klebsiella spp.
Jain A; Mondal R
Indian J Med Res; 2008 Apr; 127(4):344-6. PubMed ID: 18577788
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
J Infect; 2005 Oct; 51(3):211-7. PubMed ID: 16230218
[TBL] [Abstract][Full Text] [Related]
13. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
Tofteland S; Dahl KH; Aasnæs B; Sundsfjord A; Naseer U
Scand J Infect Dis; 2012 Dec; 44(12):927-33. PubMed ID: 22991975
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients.
Katz OT; Peled N; Yagupsky P
Eur J Clin Microbiol Infect Dis; 2004 Nov; 23(11):813-7. PubMed ID: 15480883
[TBL] [Abstract][Full Text] [Related]
15. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals.
Stobberingh EE; Arends J; Hoogkamp-Korstanje JA; Goessens WH; Visser MR; Buiting AG; Debets-Ossenkopp YJ; van Ketel RJ; van Ogtrop ML; Sabbe LJ; Voorn GP; Winter HL; van Zeijl JH
Infection; 1999; 27(6):348-54. PubMed ID: 10624595
[TBL] [Abstract][Full Text] [Related]
17. Screening and confirmatory testing for extended spectrum beta-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates.
Hadziyannis E; Tuohy M; Thomas L; Procop GW; Washington JA; Hall GS
Diagn Microbiol Infect Dis; 2000 Feb; 36(2):113-7. PubMed ID: 10705053
[TBL] [Abstract][Full Text] [Related]
18. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods.
Nyberg SD; Meurman O; Jalava J; Rantakokko-Jalava K
Scand J Infect Dis; 2008; 40(5):355-62. PubMed ID: 17934979
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil.
Wollheim C; Guerra IM; Conte VD; Hoffman SP; Schreiner FJ; Delamare AP; Barth AL; Echeverrigaray S; Costa SO
Braz J Infect Dis; 2011; 15(2):138-43. PubMed ID: 21503400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
